Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta

Acta Paediatrica, International Journal of Paediatrics

Volumn 87, Issue 1, 1998, Pages 64-68

  Astrom E ^a,b   Soderhall S ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

Bisphosphonate; Children; Osteogenesis imperfecta; Treatment

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ADULT; ARTICLE; BONE DENSITY; BONE METASTASIS; BONE TURNOVER; CALCIUM BLOOD LEVEL; CASE REPORT; DAILY LIFE ACTIVITY; DRUG EFFECT; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; OSTEOGENESIS IMPERFECTA; PHENOTYPE; PRIORITY JOURNAL; WELLBEING;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; ALKALINE PHOSPHATASE; BONE DENSITY; CHILD; DENSITOMETRY, X-RAY; DIPHOSPHONATES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; OSTEOCALCIN; OSTEOGENESIS IMPERFECTA; PAIN MEASUREMENT; PROCOLLAGEN; TREATMENT OUTCOME;

EID: 0031908506     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035259850157895     Document Type: Article

References (17)

1. Sillence DO, Rimon DL, Danks DM. Clinical variability in osteogenesis imperfecta. Variable expressivity or genetic heterogeneity. Birth Defects 1979; 15: 113-29
2. Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Gen 1979; 16: 101-16
3. Prockop DJ, Colige A, Helminen H, Khillan JS, Pereira R, Vandenberg P. Mutations in type 1 procollagen that cause osteogenesis imperfecta. Effects of the mutations on the assembly of collagen into fibrils, the basis of phenotypic variations and potential antisense therapies. J Bone Min Res 1993; 8 Suppl 2: 489-92
4. Byers PH. Osteogenesis imperfecta. Connective tissue and its heritable disorders. New York: Wiley-Liss, 1993: 317-50
5. Castells S, Colbert C, Chakrabarti C, Bachtell RS, Kassner EG, Yasumra S. Therapy of osteogenesis imperfecta with synthetic-salmon calcitonin. J Pediatr 1979; 95: 807-1
6. Nishi Y, Hamamoto K, Kajiyama M, Ono H, Kihara M, Jinno K. Effect of long-term calcitonin therapy by injections and nasal spray on the incidence of fractures in osteogenesis imperfecta. J Pediatr 1992; 121: 477-80
7. Boonekamp PM, van der Wee-Pals LJ, van Wijk-van Lennep MM, Thesing CW, Bijvoet OL. Two models of action of bisphosphonates on osteoclastic resorption of mineralized matrix. Bone Mineral 1986; 1: 27-39
8. Elomaa I, Blomqvist C, Porkka L, Holmström T, Laine H. Long-term effects of dichloromethylene diphosphonate in patients with osteolytic bone metastases and coincident primary hyperparathyroidism. Cancer Treatment Rep 1984; 68: 655-7
9. Valkema R, Vismans FJ, Papapoulos SE, Pauwels EK, Bijvoet OL. Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD. Bone Mineral 1989; 5: 183-92
10. Harnik HIJ, Bijvoet OLM, Van der Meer JVH, Jones B, Onvlee GJ. Regression of bone lesions in Gaucher's disease during treatment with aminohydroxypropylidene bisphosphonate. Lancet 1984; 1: 513
11. Devogelaer JP, Malghem J, Maldague B, Nagant de Deuxchaisnes C. Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta. Skeletal Radiol 1987; 16: 360-3
12. Huaux JP, Lokietek W. Is APD a promising drug in the treatment of severe osteogenesis imperfecta? J Pediatr Orthopaedics 1988; 8: 71-2
13. Pepper WW, Mazess RB. Total body bone mineral and lean body mass by dual-photon absorptiometry. I. Theory and measurement procedure. Calcified Tissue Int 1981; 33: 353-9
14. Kroger H, Heikkinen J, Laitinen K, Kotaniemi A. Dual-energy x-ray absorptiometry in normal women: a cross-sectional study of 717 Finnish volunteers. Osteoporosis Int 1992; 2: 135-40
15. Söderhäll S, Åströrn E, Skoog M, Rehnberg L. Improvement of pain and life quality during APD treatment of a girl with osteogenesis imperfecta type III. [Abstract]. Fifth International Conference on Osteogenesis Imperfecta, Oxford, 1993: 78
16. Chines A, Petersen D, Schranck F, Whyte M. Hypercalciuria in children severely affected with osteogenesis imperfecta. J Pediatr 1991; 119: 51-7
17. Zionts LE, Nash JP, Rude R, Ross T, Scott NS. Bone mineral density in children with mild osteogenesis imperfecta. J Bone Joint Surg 1995; 77: 143-7